CervoMed Inc. (CRVO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CervoMed Inc.

    NASDAQ: CRVO · Real-Time Price · USD
    10.51
    0.30 (2.94%)
    At close: Sep 05, 2025, 3:59 PM
    10.00
    -4.85%
    After-hours: Sep 05, 2025, 07:30 PM EDT

    CervoMed Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.74M 7.14M n/a n/a
    Cost of Revenue
    		 18.8M 8.44M 1.34M 93.42K
    Gross Profit
    		 -9.06M -1.29M -1.34M -93.42K
    Operating Income
    		 -18.23M -7.81M -3.48M -16.04M
    Interest Income
    		 1.94M 219.43K 62.23K 137.49K
    Pretax Income
    		 -16.29M -2.17M -5.8M -24.54M
    Net Income
    		 -16.29M -2.17M -5.8M -24.1M
    Selling & General & Admin
    		 9.17M 6.52M 2.14M 7.45M
    Research & Development
    		 18.8M 8.44M 1.34M 8.5M
    Other Expenses
    		 n/a -8.44M 1K 1K
    Operating Expenses
    		 27.96M 6.52M 3.48M 15.95M
    Interest Expense
    		 n/a n/a 587.00 n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 27.96M 14.96M 3.48M 16.04M
    Income Tax Expense
    		 n/a n/a n/a -444K
    Shares Outstanding (Basic)
    		 8.07M 2.66M 518.14K 1.3M
    Shares Outstanding (Diluted)
    		 8.07M 2.66M 518.14K 1.3M
    EPS (Basic)
    		 -2.02 -0.82 -11.2 -18.51
    EPS (Diluted)
    		 -2.02 -0.82 -11.2 -18.51
    EBITDA
    		 -18.23M -2.17M -5.8M -24.45M
    EBIT
    		 -18.23M -2.17M -5.8M -24.54M
    Depreciation & Amortization
    		 n/a -5 3.48M 93.42K

    Add to Watchlist